San Diego, California-based ResMed Inc. (RMD) develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. Valued at $31.5 billion, the company operates in two segments: Sleep and Breathing Health, and Residential Care Software.
Companies with a market cap of $10 billion or more are typically called “large-cap stocks.” RMD fits squarely into that category, with a market cap above this threshold that reflects its substantial size and influence in the medical instruments and supplies industry.